Abstract
Background: The dicarbonyl compounds methylglyoxal (MG), glyoxal (GO) and 3-deoxyglucosone (3-DG) have been linked to various diseases. However, disease-independent phenotypic and genotypic association studies with phenome-wide and genome-wide reach, respectively, have not been provided.
Methods: MG, GO and 3-DG were measured by LC-MS in 1304 serum samples of two populations (KORA, n = 482; BiDirect, n = 822) and assessed for associations with genome-wide SNPs (GWAS) and with phenome-wide traits. Redundancy analysis (RDA) was used to identify major independent trait associations.
Findings: Mutual correlations of dicarbonyls were highly significant, being stronger between MG and GO (ρ = 0.6) than between 3-DG and MG or GO (ρ = 0.4). Significant phenotypic results included associations of all dicarbonyls with sex, waist-to-hip ratio, glomerular filtration rate (GFR), gamma-glutamyltransferase (GGT), and hypertension, of MG and GO with age and C-reactive protein, of GO and 3-DG with glucose and antidiabetics, of MG with contraceptives, of GO with ferritin, and of 3-DG with smoking. RDA revealed GFR, GGT and, in case of 3-DG, glucose as major contributors to dicarbonyl variance. GWAS did not identify genome-wide significant loci. SNPs previously associated with glyoxalase activity did not reach nominal significance. When multiple testing was restricted to the lead SNPs of GWASs on the traits selected by RDA, 3-DG was found to be associated (p = 2.3 × 10−5) with rs1741177, an eQTL of NF-κB inhibitor NFKBIA.
Interpretation: This large-scale, population-based study has identified numerous associations, with GFR and GGT being of pivotal importance, providing unbiased perspectives on dicarbonyls beyond the current state.
Funding: Deutsche Forschungsgemeinschaft, Helmholtz Munich, German Centre for Cardiovascular Research (DZHK), German Federal Ministry of Research and Education (BMBF).
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 105007 |
| Zeitschrift | eBioMedicine |
| Jahrgang | 101 |
| Seiten (von - bis) | 105007 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 03.2024 |
Fördermittel
We thank all participants for their long-term commitment to the KORA and BiDirect studies, the staff of the studies for design, data collection, and management. The KORA study ( https://www.helmholtz-munich.de/en/epi/cohort/kora ) was initiated and financed by Helmholtz Munich which is funded by the German Federal Ministry of Education and Research BMBF and by the State of Bavaria . Data collection in the KORA study is done in cooperation with the University Hospital of Augsburg. The BiDirect Study ( https://www.medizin.uni-muenster.de/en/epi/research/projects/bidirect.html ) is supported by grants of the German Ministry of Research and Education BMBF to the University of Muenster ( 01ER0816 and 01ER1506 ). Furthermore, this work was supported by grants from the German Centre for Cardiovascular Research DZHK to MS ( 81Z0700109 ) and from the Deutsche Forschungsgemeinschaft (DFG) to TF and PPN. We also thank Christine Eichholz from the Bioanalytic Core facility ( University of Lübeck ) for her support during sample preparation and extraction. Deutsche Forschungsgemeinschaft, Helmholtz Munich, German Centre for Cardiovascular Research (DZHK), German Federal Ministry of Research and Education (BMBF).We thank all participants for their long-term commitment to the KORA and BiDirect studies, the staff of the studies for design, data collection, and management. The KORA study (https://www.helmholtz-munich.de/en/epi/cohort/kora) was initiated and financed by Helmholtz Munich which is funded by the German Federal Ministry of Education and Research BMBF and by the State of Bavaria. Data collection in the KORA study is done in cooperation with the University Hospital of Augsburg. The BiDirect Study (https://www.medizin.uni-muenster.de/en/epi/research/projects/bidirect.html) is supported by grants of the German Ministry of Research and Education BMBF to the University of Muenster (01ER0816 and 01ER1506). Furthermore, this work was supported by grants from the German Centre for Cardiovascular Research DZHK to MS (81Z0700109) and from the Deutsche Forschungsgemeinschaft (DFG) to TF and PPN. We also thank Christine Eichholz from the Bioanalytic Core facility (University of Lübeck) for her support during sample preparation and extraction.
| Träger | Trägernummer |
|---|---|
| German Centre for Cardiovascular Research (DZHK) | 81Z0700109 |
| German Ministry of Research and Education BMBF | |
| Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt | |
| University of Muenster | 01ER0816, 01ER1506 |
| Deutsches Zentrum für Herz-Kreislaufforschung | |
| Deutsche Forschungsgemeinschaft | |
| Bundesministerium für Bildung und Forschung |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)
DFG-Fachsystematik
- 2.22-09 Pharmakologie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Phenotypic and genome-wide studies on dicarbonyls: major associations to glomerular filtration rate and gamma-glutamyltransferase activity“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver